Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Trial details
- Registry ID
- NCT03442751
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusNCT03442751 | Glaukos Corporation | Phase 3 | Completed | 2019-11-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |